DIALCAT: Diabetes as an accelerator of cognitive impairment and Alzheimer’s disease, comprehensive approach and adherence to treatment

Authors

  • Cristian Barrué Universitat Politécnica de Catalunya, Computer Science Department, Barcelona
  • Roger Vila Universitat Politécnica de Catalunya, Computer Science Department, Barcelona
  • Antonio B. Martinez Universitat Politécnica de Catalunya, Computer Science Department, Barcelona
  • Mario Martín Universitat Politècnica de Catalunya, Computer Science Department, Barcelona
  • Javier Vázquez Salceda Universitat Politècnica de Catalunya, Computer Science Department, Barcelona
  • Rafael Simó Vall d’Hebron Institut de Recerca (VHIR), Barcelona
  • Marta Barroso Universitat Politécnica de Catalunya, Computer Science Department, Barcelona
  • Ulises Cortés Computer Science Department. Universitat Politécnica de Catalunya, Barcelona

DOI:

https://doi.org/10.13053/cys-23-2-3198

Keywords:

eHealth, active and assisted living, diabetes, mild cognitive impairment, treatment adherence, mHealth

Abstract

In this article, we present the designof an mHealth system to support senior citizens with chronic diseases in managing their adherenceto pharmacological treatment. The DIALCAT system consisting of a smart pill dispenser and a mobile application will be tested in a clinical study for 18 months by patients suffering diabetes with mild cognitive impairment. The clinical trial aims to study the effectof diabetes as an accelerator of cognitive impairment and Alzheimer’s disease and the impact of adherenceto treatment. DIALCAT is a RIS3CAT project co-fundedunder the European ERDF programme.

Downloads

Published

2019-06-27